🇺🇸 FDA
Pipeline program

Standard of care plus Epoprostenol infusion for 8 hours (hrs) per day up to 5 days maximum

25-0256

Approved small_molecule active

Quick answer

Standard of care plus Epoprostenol infusion for 8 hours (hrs) per day up to 5 days maximum for Frostbite is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Frostbite
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials